Highest development stage: Phase 2

Development status: Inactive

Gram-positive activity

Mechanism of Action/Target pathogen: Orally available prodrug ester of GV104326, improved activity against gram positive pathogens.

Reason dropped: Discontinued in 1999

Additional information: Hammond.S,M., et al. "GV118819 an orally absorbed prodrug ester of the tribactam GV104326"" Program and Abstracts of the 32st Intersci. Conf. on Antimicrob. Agents Chemother. No. 130.